Photo from Kai Rejeski/x
Apr 27, 2025, 09:30
Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
MSK Department of Medicine shared an article by Kai Rejeski et al. on X:
“Congrats to Kai Rejeski, Roni Shouval, and their team on developing a new grading system to evaluate patterns of thrombocytopenia in patients treated with commercial CD19 CAR-T therapy for B-cell non-Hodgkin lymphoma.”
Title: T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
Authors: Kai Rejeski, Jaime Sanz, Roni Shouval, et al.
Journal: Blood, April 2025
More posts featuring MSK Department of Medicine.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 27, 2025, 09:30
Apr 27, 2025, 09:26
Apr 27, 2025, 09:14
Apr 27, 2025, 09:05
Apr 27, 2025, 08:55
Apr 27, 2025, 08:53
Apr 27, 2025, 08:49
Apr 27, 2025, 08:46
Apr 27, 2025, 08:26